Viewing nowRofshin Tablet 250mg (Ciprofloxacin Hydrochloride Hydrate)
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Bionex Co., Ltd.

MFDS item code 199400540 · Notified 1994.09.26 · Insurance code 643100260
Treatment of various bacterial infections (e.g., urinary tract, respiratory, and skin infections)
This medication is effective against various bacteria such as Escherichia coli, Shigella, and Salmonella and is used for various infections. It is effective for respiratory infections excluding acute bronchitis and community-acquired pneumonia, and is also used for ear, nose, and throat infections. Additionally, it is used to treat bacterial prostatitis, acute uncomplicated cystitis, and acute pyelonephritis, as well as gonococcal cervicitis and gonococcal urethritis. It also helps in the treatment of gastrointestinal infections, infections of the biliary tract, skin and soft tissue infections, and bone and joint infections. However, it is only used in certain diseases when there are no other therapeutic options, and care must be taken regarding side effects. Overall, it is effective for treating various infections and is used to improve patient conditions.
○ The usual adult dose of ciprofloxacin is 250 ~ 500 mg per dose, administered orally 2 times daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose, 2 times daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms have disappeared. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, 2 times daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only the serum creatinine is known, creatinine clearance can be calculated using the following formulas: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment, but the patient's condition should be carefully monitored after administration. The dose may be adjusted according to symptoms.
This medication can cause serious side effects, including tendinitis or tendon rupture, peripheral neuropathy, central nervous system abnormal reactions, and exacerbation of myasthenia gravis. Special caution should be taken as the risk of tendinitis or tendon rupture is higher in elderly patients or those with renal impairment or when taken with corticosteroids. Patients with severe myasthenia gravis should not be treated with this medication as it may worsen symptoms. Women who are pregnant or could become pregnant, nursing mothers, adolescents under 18 years of age, patients with a history of epilepsy, and those who have had hypersensitivity reactions to this drug or similar drugs should not use it. Additionally, caution is required for patients taking certain medications, as the risk of side effects may increase when taking drugs like tizanidine or ketoprofen. This medication should be used with caution in patients with severe renal impairment, those with a history of seizure disorders, elderly people, and patients with central nervous system conditions. Side effects like altered glucose levels, liver function abnormalities, neurological issues, and cardiovascular issues may also occur, requiring careful monitoring. If any symptoms such as rash, muscle pain, visual changes, severe diarrhea, or changes in mental status occur during treatment, immediate consultation with a physician is necessary. Furthermore, this drug may interact with various other medications, so patients should inform healthcare professionals of any other medications they are taking. The use of this medication is not recommended during pregnancy or lactation, especially during lactation, breastfeeding should be stopped or the medication avoided. Its safety has not been established for children and growing adolescents, so it is best not to use it in these populations. Elderly individuals should use this medication cautiously due to the potential for prolonged retention in the body due to decreased renal function, necessitating adjustments to dosage and administration intervals. Overdosage poses a risk of renal damage, so prescribed doses should be strictly adhered to. This medication should be stored away from direct sunlight and ultraviolet light and kept out of reach of children.
Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, granuloctyopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reaction, anaphylactoid shock, serum sickness-like reaction, loss of appetite, decreased food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, decreased sensation, taste loss, tremors, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, visual disturbances, color vision disturbances, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, torsades de pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, colitis with bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver impairment, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, pruritus, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and spasms, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, increased serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, unexplained pain, discomfort, fever, asthenia, edema, sweating, gait disturbance, maculopapular rash, purpuric rash, aortic aneurysm, aortic dissection, heart valve regurgitation, heart valve insufficiency, shock, hypotension, chest tightness, muscle weakness, increased creatine kinase, elevated serum and urinary myoglobin, rhabdomyolysis, cough, abnormal chest X-ray findings, eosinophilia, interstitial pneumonia, visual impairment, increased risk of retinal detachment
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure, and it is best kept at room temperature between 1°C and 30°C. This storage method helps maintain the medication's effectiveness and prevents degradation.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCiprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Bionex Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.